These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9856569)

  • 21. Loss of H19 imprinting and up-regulation of H19 and SNRPN in a case with malignant mixed Müllerian tumor of the uterus.
    Hashimoto K; Azuma C; Tokugawa Y; Nobunaga T; Aki TA; Matsui Y; Yanagida T; Izumi H; Saji F; Murata Y
    Hum Pathol; 1997 Jul; 28(7):862-5. PubMed ID: 9224757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
    Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK
    Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
    Wake N; Arima T; Matsuda T
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-8. PubMed ID: 9833609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions.
    Ishizaki T; Yoshie M; Yaginuma Y; Tanaka T; Ogawa K
    J Biol Chem; 2003 Feb; 278(8):6222-8. PubMed ID: 12475990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
    Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
    Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma.
    el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V
    Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
    Stier S; Neuhaus T; Albers P; Wernert N; Grünewald E; Forkert R; Vetter H; Ko Y
    Arch Toxicol; 2006 Oct; 80(10):713-8. PubMed ID: 16721595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor.
    Frevel MA; Sowerby SJ; Petersen GB; Reeve AE
    J Biol Chem; 1999 Oct; 274(41):29331-40. PubMed ID: 10506193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19.
    Hu JF; Vu TH; Hoffman AR
    J Biol Chem; 1997 Aug; 272(33):20715-20. PubMed ID: 9252392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
    Wada M; Seeger RC; Mizoguchi H; Koeffler HP
    Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome.
    Squire JA; Li M; Perlikowski S; Fei YL; Bayani J; Zhang ZM; Weksberg R
    Genomics; 2000 May; 65(3):234-42. PubMed ID: 10857747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
    Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R
    Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancer competition between H19 and Igf2 does not mediate their imprinting.
    Schmidt JV; Levorse JM; Tilghman SM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9733-8. PubMed ID: 10449763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proinsulin-like growth factor-II overexpression does not alter monoallelic H19 gene expression in transfected human embryonic kidney fibroblasts.
    Kiess W; Paquette J; Koepf G; Wolf E; Deal C
    Biochem Biophys Res Commun; 1999 Feb; 255(2):226-30. PubMed ID: 10049690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.
    Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K
    Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
    Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
    Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic imprinting and Wilms' tumor.
    Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
    Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Igf2 imprinting does not require its own DNA methylation or H19 RNA.
    Jones BK; Levorse JM; Tilghman SM
    Genes Dev; 1998 Jul; 12(14):2200-7. PubMed ID: 9679064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells.
    Liu J; Kahri AI; Heikkilä P; Voutilainen R
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1766-71. PubMed ID: 9177379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
    Rainho CA; Kowalski LP; Rogatto SR
    Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.